Additionally, the risk of endometrial cancer is notably high among carriers of MMR gene mutations, especially for those with MLH1 and MSH2 mutations, where it is estimated to be between 40 and 60% by age 70 [17]. The gene discussed is MSH2; the disease is endometrial cancer.